Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

Affiliations

¹ Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Instituto Valenciano de Oncologia, Valencia, Spain apoveda@fivo.org.
² Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), University Pierre et Marie Curie-Sorbonne, Tenon Hospital, Hôpitaux Universitaires de l'Est Parisien-Assistance Publique-Hôpitaux de Paris, and Alliance Pour la Recherche en Cancérologie, Paris, France.
³ Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany.
⁴ AGO and Coordinating Center for Clinical Trials, Marburg, Germany.
⁵ Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies and Regina Elena National Cancer Institute, Rome, Italy.
⁶ Belgian Gynaecological Oncology Group and University Hospital Leuven, Leuven, Belgium.
⁷ Dutch Gynaecological Oncology Group and University Medical Center Utrecht, Utrecht, the Netherlands.
⁸ Hellenic Cooperative Oncology Group and University of Athens, Athens, Greece.
⁹ F. Hoffmann-La Roche, Basel, Switzerland.
¹⁰ GINECO and Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.

Clinical Trial

Andres M Poveda et al. J Clin Oncol. 2015.

. 2015 Nov 10;33(32):3836-8.

doi: 10.1200/JCO.2015.63.1408. Epub 2015 Aug 17.

¹ Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Instituto Valenciano de Oncologia, Valencia, Spain apoveda@fivo.org.
² Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), University Pierre et Marie Curie-Sorbonne, Tenon Hospital, Hôpitaux Universitaires de l'Est Parisien-Assistance Publique-Hôpitaux de Paris, and Alliance Pour la Recherche en Cancérologie, Paris, France.
³ Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany.
⁴ AGO and Coordinating Center for Clinical Trials, Marburg, Germany.
⁵ Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies and Regina Elena National Cancer Institute, Rome, Italy.
⁶ Belgian Gynaecological Oncology Group and University Hospital Leuven, Leuven, Belgium.
⁷ Dutch Gynaecological Oncology Group and University Medical Center Utrecht, Utrecht, the Netherlands.
⁸ Hellenic Cooperative Oncology Group and University of Athens, Athens, Greece.
⁹ F. Hoffmann-La Roche, Basel, Switzerland.
¹⁰ GINECO and Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.

No abstract available

Publication types